Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA gene

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1682-1686

  Szakacs, Tom A ^a   Kalan, Lindsay ^b   McConnell, Michael J ^a,f   Eshaghi, Alireza ^c   Shahinas, Dea ^c   McGeer, Allison ^d,e   Wright, Gerry D ^b   Low, Donald E ^d,e   Patel, Samir N ^c,d  

^a Brant Community Healthcare System   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c PUBLIC HEALTH ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; LINEZOLID; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN; AGAR; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CULTURE MEDIUM;

AGAR DIFFUSION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EPIDEMIC; FEMALE; GENE CLUSTER; GENOTYPE; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE HOMOLOGY; TRANSPOSON; VANA GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; CULTURE MEDIUM; DRUG EFFECTS; GENETICS; GRAM-POSITIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

AGAR; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CULTURE MEDIA; DISEASE OUTBREAKS; ENTEROCOCCUS FAECIUM; FEMALE; GENES, BACTERIAL; GENOTYPE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84899528433     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03563-13     Document Type: Article

References (24)

1. Woodford N. 2001. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb. Drug Resist. 7:229-236. http://dx.doi.org/10.1089/10766290152652774.
2. Leclercq R, Derlot E, Duval J, Courvalin P. 1988. Plasmid-mediated resistancetovancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161. http://dx.doi.org/10.1056/NEJM198807213190307.
3. Ofner-Agostini M, Johnston BL, Simor AE, Embil J, Matlow A, Mulvey M, Ormiston D, Conly J, Canadian Nosocomial Infection Surveillance Program. 2008. Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005. Infect. Control Hosp Epidemiol. 29:271-274. http://dx.doi.org/10.1086/528812.
4. Arthur M, Courvalin P. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-1571. http://dx.doi.org/10.1128/AAC.37.8.1563.
5. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. 2002. Health and economic outcomes of vancomycin-resistant enterococci. Arch. Intern. Med. 162:2223-2228. http://dx.doi.org/10.1001/archinte.162.19.2223.
6. Provincial Infectious Diseases Advisory Committee. 2013. Screening, testing and surveillance for antibiotic-resistant organisms (AROs) in all health care settings. http://www.publichealthontario.ca/en/eRepository/PIDAC-IPC- Annex-A-Screening-Testing-Surveillance-AROs-2013.pdf. Accessed 3 December 2013.
7. Elsayed S, Hamilton N, Boyd D, Mulvey M. 2001. Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp J. Clin. Microbiol. 39:2367-2368. http://dx.doi.org/10.1128/JCM.39.6.2367-2368.2001.
8. Boyd DA, Du T, Hizon R, Kaplen B, Murphy T, Tyler S, Brown S, Jamieson F, Weiss K, Mulvey MR. 2006. VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada. Antimicrob. Agents Chemother. 50:2217-2221. http://dx.doi.org/10.1128/AAC.01541-05.
9. Boyd DA, Kibsey P, Roscoe D, Mulvey MR. 2004. Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operon. J. Antimicrob. Chemother. 54:680-683. http://dx.doi.org/10.1093/jac/dkh391.
10. Boyd DA, Cabral T, Van Caeseele P, Wylie J, Mulvey MR. 2002. Molecular characterization of the vanE gene cluster in vancomycinresistant Enterococcus faecalis N00-410 isolated in Canada. Antimicrob. Agents Chemother. 46:1977-1979. http://dx.doi.org/10.1128/AAC.46.6.1977-1979.2002.
11. Huh JY, Lee WG, Lee K, Shin WS, Yoo JH. 2004. Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. J. Clin. Microbiol. 42:1897-1902. http://dx.doi.org/10.1128/JCM.42.5.1897-1902.2004.
12. Willems RJ, Top J, van den Braak N, van Belkum A, Mevius DJ, Hendriks G, van Santen-Verheuvel M, van Embden JD. 1999. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob. Agents Chemother. 43:483-491. http://dx.doi.org/10. 1093/jac/43.4.483.
13. Lee WG, Huh JY, Cho SR, Lim YA. 2004. Reduction in glycopeptide resistance in vancomycin-resistant enterococci as a result of vanA cluster rearrangements. Antimicrob. Agents Chemother. 48:1379-1381. http://dx.doi.org/ 10.1128/AAC.48.4.1379-1381.2004.
14. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer ML, Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF, Rothberg JM. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376-380. http://dx.doi.org/10.1038/nature03959.
15. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410. http://dx.doi.org/10.1016/ S0022-2836 (05) 80360-2.
16. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. 1990. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J. Clin. Microbiol. 28:2059-2063.
17. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
18. Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, Van Embden JD, Willems RJ. 2002. Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Microbiol. 40:1963-1971. http://dx.doi.org/10.1128/JCM.40.6.1963-1971. 2002.
19. Provincial Infectious Diseases Advisory Committee. 2012. Routine practices and additional precautions in all health care settings, 3rd ed. http://www.publichealthontario.ca/en/eRepository/RPAP-All-HealthCare-Settings- Eng2012.pdf. Accessed 3 December 2013.
20. Hong HJ, Hutchings MI, Buttner MJ, Biotechnology Biological Sciences Research Council UK. 2008. Vancomycin resistance VanS/VanR two-component systems. Adv. Exp. Med. Biol. 631:200-213. http://dx.doi.org/10.1007/978-0-387- 78885-2-14.
21. Choi HJ, Nam D, Peck KR, Song JH, Shin D, Ko KS. 2011. Loss of vancomycin resistance not completely dependent on the Tn1546 element in Enterococcus faecium isolates. Diagn. Microbiol. Infect. Dis. 69:105-110. http://dx.doi.org/10.1016/j.diagmicrobio.2010.08.030.
22. Grady R, Hayes F. 2003. Axe-Txe, a broad-spectrum proteic toxinantitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol. Microbiol. 47:1419-1432. http://dx.doi.org/10.1046/j.1365-2958. 2003.03387.x.
23. Halvorsen EM, Williams JJ, Bhimani AJ, Billings EA, Hergenrother PJ. 2011. Txe, an endoribonuclease of the enterococcal Axe-Txe toxinantitoxin system, cleaves mRNA and inhibits protein synthesis. Microbiology 157:387-397. http://dx.doi.org/10.1099/mic.0.045492-0.
24. Coburn B, Low DE, Patel SN, Pouteanen SM, Shahinas D, Eshaghi A, Willey BM, McGeer A. 2014. Vancomycin-variable Enterococcus faecium: in vivo emergence of vancomycin resistance in a vancomycinsusceptible isolate. J. Clin. Microbiol. 52:1766-1767. http://dx.doi.org/10.1128/JCM.03579-13.